However, NDRG1 overexpression led to reduced proliferation in estrogen receptor-positive (ER+) MCF7 cells, while having the opposite effect in triple-negative breast cancer (TNBC) cells, indicating a cell type-dependent response. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.